Valuation: Lonza Group AG

Capitalization 39.27B 48.93B 42.19B 36.56B 68.07B 4,440B 73.24B 452B 178B 2,118B 184B 180B 7,733B P/E ratio 2025 *
38.9x
P/E ratio 2026 * 32.1x
Enterprise value 42.74B 53.25B 45.91B 39.78B 74.08B 4,831B 79.7B 492B 194B 2,305B 200B 196B 8,415B EV / Sales 2025 *
5.65x
EV / Sales 2026 * 5.19x
Free-Float
93.86%
Yield 2025 *
0.88%
Yield 2026 * 1%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.89%
1 week+1.01%
Current month+3.98%
1 month+6.76%
3 months+1.01%
6 months-1.89%
Current year+3.98%
More quotes
1 week 556
Extreme 556
572.6
1 month 522.2
Extreme 522.2
572.6
Current year 522.2
Extreme 522.2
572.6
1 year 467.8
Extreme 467.8
616
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 133.5
Extreme 133.5
785.4
More quotes
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2024
Director of Finance/CFO 54 01/12/2021
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 16/04/2014
Director/Board Member 68 16/04/2014
Director/Board Member 66 26/04/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.89%+1.01%+0.87%+12.27% 48.93B
-1.49%-1.95%+20.43%+7.29% 40.48B
-0.03%+0.09%+60.98%+26.34% 37.42B
-0.71%-3.69%+20.76%+39.59% 31.03B
-2.43%+1.38%+198.54%+339.30% 23.25B
-1.16%+2.67%+81.09%+167.21% 17.21B
-0.47%+4.10%+53.22%+9.17% 14.78B
Average -1.03%+0.71%+62.27%+85.88% 30.44B
Weighted average by Cap. -0.99%+0.19%+49.71%+65.75%
See all sector performances

Financials

2025 *2026 *
Net sales 7.57B 9.43B 8.13B 7.04B 13.12B 855B 14.11B 87.04B 34.32B 408B 35.36B 34.63B 1,490B 8.24B 10.27B 8.86B 7.68B 14.29B 932B 15.38B 94.84B 37.4B 445B 38.53B 37.73B 1,624B
Net income 1.03B 1.28B 1.1B 956M 1.78B 116B 1.91B 11.81B 4.66B 55.36B 4.8B 4.7B 202B 1.24B 1.55B 1.33B 1.15B 2.15B 140B 2.31B 14.27B 5.63B 66.89B 5.8B 5.68B 244B
Net Debt 3.46B 4.32B 3.72B 3.22B 6B 392B 6.46B 39.84B 15.71B 187B 16.18B 15.85B 682B 3.54B 4.41B 3.8B 3.29B 6.13B 400B 6.6B 40.68B 16.04B 191B 16.52B 16.18B 696B
More financial data * Estimated data
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals (57.4%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.; - capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (16.5%). In addition, the group offers nutritional ingredients; - small molecule drug substances (15.3%); - technologies and platforms for manufacturing processes and production of cell and gene therapies (10.8%).
Employees
19,299
More about the company
Date Price Change Volume
16/01/26 559.20 CHF -0.89% 139,240
15/01/26 564.20 CHF +1.11% 197,070
14/01/26 558.00 CHF -0.46% 145,166
13/01/26 560.60 CHF -0.92% 127,325
12/01/26 565.80 CHF +2.20% 168,367

Delayed Quote Swiss Exchange, January 16, 2026 at 07:31 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
559.20CHF
Average target price
677.74CHF
Spread / Average Target
+21.20%
Consensus

Quarterly revenue - Rate of surprise